We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest is Mati Gill — CEO at AION Labs. Today, we’re diving into the cutting edge of biotech, AI, and venture building.

Mati’s background is as unique as the model he’s leading. He’s worked at the intersection of science, pharma, and innovation for years — and now he’s helping world-class scientist-entrepreneurs turn bold ideas into sustainable businesses that serve patients around the globe.

We’ll talk today about what makes AION’s venture studio model different, how they bring pharma giants into the same room to actually build companies, and why the future of medicine may be shaped not in massive corporations, but in small, focused teams with the right support.

Whether you’re a founder, a researcher, or just curious about how AI is changing drug R&D, this conversation will give you a front-row seat.

Let’s get into it.

Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

Now, without further ado, we’re excited to share with you the next episode in the Life Sciences Today podcast.

Be sure to subscribe to the Life Sciences Today on your favorite podcasting platform:

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube.  Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today.

If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!